source
- Astellas therapy brings new hope to rare disease patients amid broader biotech challengesA new Astellas treatment is being highlighted as a source of optimism for a community affected by a rare disease, after a period of setbacks in the program. The article also notes a revived gene t…
- Biotech layoffs slow as companies like BioNTech cut nearly 1,900 jobs amid market pressuresThe biotech sector has seen more than 40 layoff announcements through the end of April 2026, a decline from the over 50 rounds reported in the final months of 2025. Analysts had expected the pace t…